Insufficient scRNA-seq data for expression of CACNG1 at single-cell level.
Insufficient scRNA-seq data for expression of CACNG1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 72% | 41.37 | 1895 / 2642 | 78% | 3.16 | 552 / 705 |
adrenal gland | 95% | 91.79 | 246 / 258 | 38% | 1.17 | 88 / 230 |
prostate | 60% | 60.00 | 146 / 245 | 42% | 1.53 | 213 / 502 |
muscle | 100% | 10103.02 | 803 / 803 | 0% | 0 | 0 / 0 |
breast | 39% | 28.49 | 180 / 459 | 60% | 5.31 | 675 / 1118 |
ovary | 1% | 0.27 | 2 / 180 | 27% | 0.68 | 116 / 430 |
lung | 21% | 4.79 | 119 / 578 | 4% | 0.13 | 46 / 1155 |
uterus | 2% | 0.61 | 3 / 170 | 9% | 3.11 | 43 / 459 |
tonsil | 0% | 0 | 0 / 0 | 11% | 1.24 | 5 / 45 |
liver | 3% | 0.90 | 6 / 226 | 8% | 0.51 | 34 / 406 |
stomach | 6% | 1.21 | 21 / 359 | 2% | 0.04 | 7 / 286 |
peripheral blood | 8% | 11.75 | 77 / 929 | 0% | 0 | 0 / 0 |
pancreas | 1% | 0.24 | 4 / 328 | 5% | 0.18 | 9 / 178 |
thymus | 4% | 3.35 | 23 / 653 | 2% | 0.13 | 14 / 605 |
intestine | 2% | 0.55 | 22 / 966 | 2% | 0.06 | 11 / 527 |
esophagus | 3% | 2.76 | 42 / 1445 | 1% | 0.02 | 2 / 183 |
skin | 2% | 6.68 | 44 / 1809 | 1% | 0.04 | 6 / 472 |
blood vessel | 3% | 3.20 | 40 / 1335 | 0% | 0 | 0 / 0 |
adipose | 3% | 1.53 | 34 / 1204 | 0% | 0 | 0 / 0 |
heart | 2% | 0.56 | 21 / 861 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 2% | 0.06 | 12 / 504 |
spleen | 2% | 0.34 | 4 / 241 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.02 | 7 / 901 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1902514 | Biological process | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel |
GO_0070296 | Biological process | sarcoplasmic reticulum calcium ion transport |
GO_0051649 | Biological process | establishment of localization in cell |
GO_0045933 | Biological process | positive regulation of muscle contraction |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0030315 | Cellular component | T-tubule |
GO_0042383 | Cellular component | sarcolemma |
GO_0005886 | Cellular component | plasma membrane |
GO_1990454 | Cellular component | L-type voltage-gated calcium channel complex |
GO_0005246 | Molecular function | calcium channel regulator activity |
GO_0005245 | Molecular function | voltage-gated calcium channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CACNG1 |
Protein name | Voltage-dependent calcium channel gamma-1 subunit (Dihydropyridine-sensitive L-type, skeletal muscle calcium channel subunit gamma) |
Synonyms | CACNLG |
Description | FUNCTION: Regulatory subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents in skeletal muscle. Regulates channel inactivation kinetics. . |
Accessions | ENST00000226021.5 Q06432 |